Spencer Samantha, Ipema Heather, Hartke Patricia, Krueger Courtney, Rodriguez Ryan, Gross Alan E, Gabay Michael
College of Pharmacy, University of Illinois at Chicago, USA.
Hosp Pharm. 2018 Jun;53(3):157-169. doi: 10.1177/0018578718760257. Epub 2018 Mar 8.
Intravenous (IV) push administration can provide clinical and practical advantages over longer IV infusions in multiple clinical scenarios, including in the emergency department, in fluid-restricted patients, and when supplies of diluents are limited. In these settings, conversion to IV push administration may provide a solution. This review compiles available data on IV push administration of antibiotics in adults, including preparation, stability, and administration instructions. Prescribing information, multiple tertiary drug resources, and primary literature were consulted to compile relevant data. Several antibiotics are Food and Drug Administration-approved for IV push administration, including many beta-lactams. In addition, cefepime, ceftriaxone, ertapenem, gentamicin, and tobramycin have primary literature data to support IV push administration. While amikacin, ciprofloxacin, imipenem/cilastatin, and metronidazole have limited primary literature data on IV push administration, available data do not support that route. In addition, a discussion on practical considerations, such as IV push best practices and pharmacodynamic considerations, is provided.
在多种临床场景中,包括急诊科、液体受限患者以及稀释剂供应有限的情况下,静脉推注给药相较于较长时间的静脉输注具有临床和实际优势。在这些情况下,转换为静脉推注给药可能提供一种解决方案。本综述汇编了关于成人抗生素静脉推注给药的现有数据,包括制剂、稳定性和给药说明。查阅了处方信息、多个三级药物资源和原始文献以汇编相关数据。几种抗生素已获美国食品药品监督管理局批准用于静脉推注给药,包括许多β-内酰胺类抗生素。此外,头孢吡肟、头孢曲松、厄他培南、庆大霉素和妥布霉素有原始文献数据支持静脉推注给药。虽然阿米卡星、环丙沙星、亚胺培南/西司他丁和甲硝唑关于静脉推注给药的原始文献数据有限,但现有数据不支持该给药途径。此外,还提供了关于实际考虑因素的讨论,如静脉推注的最佳实践和药效学考虑因素。